custom image

RNA Editing and Modifications: From Biology to Therapy

Sept. 30-Oct. 2, 2020 | 10:00AM EDT | 2:00PM UTC*
*Program is in development and subject to change


The biochemical modifications made to RNA after transcription, called the epitranscriptome, play a critical role in life. The development of new technologies has transformed the field in recent years. Our understanding of the reason for and regulation of RNA editing and modifications, as well as their roles in human infection and disease is deepening and therapeutic applications are emerging. This virtual conference will bring together leading experts in RNA editing and modifications, technology development, and medicine to present and discuss cutting edge research. We anticipate that participants of this conference will benefit from learning the cutting edge of the rapidly advancing field and help move the field forward by creating collaboration opportunities.

Program is intended for scientific researchers and clinical audiences.

Join us for this landmark virtual event, brought to you by Keystone Symposia.

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Scholarships: September 9, 2020
Abstract Submission: September 9, 2020

#VKSRNAediting21



Financial Aid Opportunities

Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine related fields, are eligible to apply for a FREE registration code.

Find out more about financial aid opportunities here!





Program Details



Speaking at this eSymposia


Omar Abudayyeh

Massachusetts Institute of Technology, USA


Peter Beal

University of California, Davis, USA


Grace Chen

Yale University School of Medicine, USA


Jianjun Chen

Beckman Research Institute of City of Hope, USA


Eli Eisenberg

Tel Aviv University, Israel


Michaela Frye

Deutsches Krebsforschungszentrum, Germany


Chuan He

University of Chicago, USA


Stacy M. Horner

Duke University Medical Center, USA


Michael G. Kharas

Memorial Sloan Kettering Cancer Center, USA


Kamil R. Kranc

Barts Cancer Institute, Queen Mary University of London, UK


Jin Billy Li

Stanford University, USA


Kate Meyer

Duke University, USA


Yunsun Nam

University of Texas Southwestern Medical Center, USA


Kazuko Nishikura

Wistar Institute, USA


Eva Maria Novoa Pardo

Centre for Genomic Regulation, Spain


F. Nina Papavasiliou

Deutsches Krebsforschungszentrum, Germany


Alexey Ruzov

University of Nottingham, UK


Thorsten Stafforst

Universität Tübingen, Germany


Noam Stern-Ginossar

Weizmann Institute of Science, Israel


Carl Walkley

St Vincent's Institute, Australia


Blerta Xhemalce

University of Texas, Austin, USA


Yi-Tao Yu

University of Rochester Medical Center, USA


More program details will be available soon.


Subscribe to receive updates to the program for this meeting.


Email address:    





The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






Donate to Keystone Symposia


custom image